Literature DB >> 8098750

Risk of developing AIDS after primary acute HIV-1 infection.

A Sinicco1, R Fora, M Sciandra, A Lucchini, P Caramello, P Gioannini.   

Abstract

We enrolled 134 newly human immunodeficiency virus type 1 (HIV-1)-infected subjects in a prospective study to determine the natural history of the infection and evaluate the risk of developing AIDS after acute primary HIV-1 infection (API). Twenty-three patients were observed during an acute primary HIV-1 infection, and 111 were asymptomatic seroconverters. Acute primary HIV-1 infection was more frequently observed in subjects who had acquired the infection through sexual transmission. Intravenous drug users were rarely affected and presented with milder symptomatology. Patients observed with an acute primary HIV-1 infection had a significantly higher risk of developing AIDS than asymptomatic seroconverters (68% at 56 months vs. 20% at 66 months; p = 0.026). Low CD4+ cell counts at the onset of acute illness and delayed seroconversion in enzyme-linked immunosorbent assay (ELISA) were associated with evolution to AIDS in acute seroconverters (p = 0.03 and 0.02, respectively). During the follow-up, patients with an acute illness were more likely to show an early fall of CD4+ cell counts below 200/microliters than asymptomatic seroconverters. The results of this follow-up study suggest the opportunity to study antiviral treatment protocols in patients with API as a possible measure to control disease progression.

Entities:  

Mesh:

Year:  1993        PMID: 8098750

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  16 in total

1.  Primary HIV.

Authors:  J Fox; J Weber; S Fidler
Journal:  Sex Transm Infect       Date:  2006-08       Impact factor: 3.519

2.  Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS.

Authors:  E L Delwart; H Pan; H W Sheppard; D Wolpert; A U Neumann; B Korber; J I Mullins
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Rapid evolution of human immunodeficiency virus strains with increased replicative capacity during the seronegative window of primary infection.

Authors:  J Ferbas; E S Daar; K Grovit-Ferbas; W J Lech; R Detels; J V Giorgi; A H Kaplan
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

4.  Immediate immunosuppression caused by acute HIV-1 infection: a fulminant multisystemic disease 2 days post infection.

Authors:  P Ben-Galim; Y Shaked; A Vonsover; M Garty
Journal:  Infection       Date:  1996 Jul-Aug       Impact factor: 3.553

5.  Symptomatic HIV seroconverting illness is associated with more rapid neurological impairment.

Authors:  M R Wallace; J A Nelson; J A McCutchan; T Wolfson; I Grant
Journal:  Sex Transm Infect       Date:  2001-06       Impact factor: 3.519

Review 6.  Recent advances in the neurology of HIV infection.

Authors:  R K Petty
Journal:  Postgrad Med J       Date:  1994-06       Impact factor: 2.401

7.  Acute Retroviral Syndrome Is Associated With High Viral Burden, CD4 Depletion, and Immune Activation in Systemic and Tissue Compartments.

Authors:  Trevor A Crowell; Donn J Colby; Suteeraporn Pinyakorn; James L K Fletcher; Eugène Kroon; Alexandra Schuetz; Shelly J Krebs; Bonnie M Slike; Louise Leyre; Nicolas Chomont; Linda L Jagodzinski; Irini Sereti; Netanya S Utay; Robin Dewar; Rungsun Rerknimitr; Nitiya Chomchey; Rapee Trichavaroj; Victor G Valcour; Serena Spudich; Nelson L Michael; Merlin L Robb; Nittaya Phanuphak; Jintanat Ananworanich
Journal:  Clin Infect Dis       Date:  2018-05-02       Impact factor: 9.079

8.  Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.

Authors:  R I Connor; B T Korber; B S Graham; B H Hahn; D D Ho; B D Walker; A U Neumann; S H Vermund; J Mestecky; S Jackson; E Fenamore; Y Cao; F Gao; S Kalams; K J Kunstman; D McDonald; N McWilliams; A Trkola; J P Moore; S M Wolinsky
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

9.  Emergence of individual HIV-specific CD8 T cell responses during primary HIV-1 infection can determine long-term disease outcome.

Authors:  Hendrik Streeck; Richard Lu; Noor Beckwith; Mark Milazzo; Michelle Liu; Jean-Pierre Routy; Susan Little; Heiko Jessen; Anthony D Kelleher; Frederick Hecht; Rafick-Pierre Sekaly; Galit Alter; David Heckerman; Mary Carrington; Eric S Rosenberg; Marcus Altfeld
Journal:  J Virol       Date:  2014-08-27       Impact factor: 5.103

10.  Does symptomatic primary HIV-1 infection accelerate progression to CDC stage IV disease, CD4 count below 200 x 10(6)/l, AIDS, and death from AIDS?

Authors:  S Lindbäck; C Broström; A Karlsson; H Gaines
Journal:  BMJ       Date:  1994-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.